+647 A/C and +1245 MT1A polymorphisms in the susceptibility of diabetes mellitus and cardiovascular complications

Molecular Genetics and Metabolism

Volumn 94, Issue 1, 2008, Pages 98-104

  Giacconi, R ^a   Bonfigli, A R ^a   Testa, R ^a   Sirolla, C ^a   Cipriano, C ^a   Marra, M ^a   Muti, E ^a   Malavolta, M ^a   Costarelli, L ^a   Piacenza, F ^a   Tesei, S ^a   Mocchegiani, E ^a  

^a INRCA   (Italy)

Author keywords

Cardiovascular diseases; Elderly; MT polymorphism; Type 2 diabetes; Zinc

Indexed keywords

GLUCOSE; GLYCOSYLATED HEMOGLOBIN; METALLOTHIONEIN 1A; METALLOTHIONEIN I; UNCLASSIFIED DRUG; ZINC;

ADULT; AGED; ALLELE; ARTICLE; CARDIOVASCULAR DISEASE; COHORT ANALYSIS; CONTROL GROUP; CONTROLLED STUDY; FEMALE; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; GLUCOSE BLOOD LEVEL; HEMOGLOBIN BLOOD LEVEL; HETEROZYGOTE; HUMAN; MAJOR CLINICAL STUDY; MALE; MODULATION; NON INSULIN DEPENDENT DIABETES MELLITUS; PREVALENCE; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; ZINC BLOOD LEVEL;

AGED; CARDIOVASCULAR DISEASES; DIABETES COMPLICATIONS; DIABETES MELLITUS, TYPE 2; FEMALE; FLOW CYTOMETRY; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MALE; METALLOTHIONEIN; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; ZINC;

EID: 41949102406     PISSN: 10967192     EISSN: 10967206     Source Type: Journal    
DOI: 10.1016/j.ymgme.2007.12.006     Document Type: Article

References (47)

1. Stirban A., Negrean M., Stratmann B., Gawlowski T., Horstmann T., Gotting C., Kleesiek K., Mueller-Roesel M., Koschinsky T., Uribarri J., Vlassara H., and Tschoepe D. Benfotiamine prevents macro- and microvascular endothelial dysfunction and oxidative stress following a meal rich in advanced glycation end products in individuals with type 2 diabetes. Diab. Care 29 (2006) 2064-2071
2. Ceriello A. Controlling oxidative stress as a novel molecular approach to protecting the vascular wall in diabetes. Curr. Opin. Lipidol. 17 (2006) 510-518
3. Di Filippo C., Cuzzocrea S., Rossi F., Marfella R., and D'Amico M. Oxidative stress as the leading cause of acute myocardial infarction in diabetics. Cardiovasc. Drug Rev. 24 (2006) 77-87
4. Maret W., and Krezel A. Cellular zinc and redox buffering capacity of metallothionein/thionein in health and disease. Mol. Med. 13 (2007) 371-375
5. Kang Y.J. Metallothionein redox cycle and function. Exp. Biol. Med. (Maywood) 231 (2006) 1459-1467
6. Kumari M.V., Hiramatsu M., and Ebadi M. Free radical scavenging actions of metallothionein isoforms I and II. Free Radic. Res. 29 (1998) 93-101
7. Haase H., and Rink L. Signal transduction in monocytes: the role of zinc ions. Biometals 20 (2007) 579-585
8. Katakai K., Liu J., Nakajima K., Keefer L.K., and Waalkes M.P. Nitric oxide induces metallothionein (MT) gene expression apparently by displacing zinc bound to MT. Toxicol. Lett. 119 (2001) 103-108
9. Zangger K., Oz G., Haslinger E., Kunert O., and Armitage I.M. Nitric oxide selectively releases metals from the N-terminal domain of metallothioneins: potential role at inflammatory sites. FASEB J. 15 (2001) 1303-1305
10. St Croix C.M., Wasserloos K.J., Dineley K.E., Reynolds I.J., Levitan E.S., and Pitt B.R. Nitric oxide-induced changes in intracellular zinc homeostasis are mediated by metallothionein/thionein. Am. J. Physiol. Lung Cell. Mol. Physiol. 282 (2002) L185-L192
11. 2+ release. Proc. Natl. Acad. Sci. USA 100 (2003) 13952-13957
12. DiSilvestro R.A. Zinc in relation to diabetes and oxidative disease. J. Nutr. 130 (2000) 1509S-1511S
13. Giacconi R., Caruso C., Lio D., Muti E., Cipriano C., Costarelli L., Saba V., Gasparini N., Malavolta M., and Mocchegiani E. CD14 C (-260)T polymorphism, atherosclerosis, elderly: role of cytokines and metallothioneins. Int. J. Cardiol. 120 (2007) 45-51
14. Reunanen A., Knekt P., Marniemi J., Maki J., Maatela J., and Aromaa A. Serum calcium, magnesium, copper and zinc and risk of cardiovascular death. Eur. J. Clin. Nutr. 50 (1996) 431-437
15. Beletate V., El Dib R., and Atallah A. Zinc supplementation for the prevention of type 2 diabetes mellitus. Cochrane Database Syst. Rev. 24 (2007) CD005525
16. Faure P., Benhamou P.Y., Perard A., Halimi S., and Roussel A.M. Lipid peroxidation in insulin-dependent diabetic patients with early retina degenerative lesions: effects of an oral zinc supplementation. Eur. J. Clin. Nutr. 49 (1995) 282-288
17. Ye G., Metreveli N.S., Ren J., and Epstein P.N. Metallothionein prevents diabetes-induced deficits in cardiomyocytes by inhibiting reactive oxygen species production. Diabetes 52 (2003) 777-783
18. Cai L., Wang Y., Zhou G., Chen T., Song Y., Li X., and Kang Y.J. Attenuation by metallothionein of early cardiac cell death via suppression of mitochondrial oxidative stress results in a prevention of diabetic cardiomyopathy. J. Am. Coll. Cardiol. 48 (2006) 1688-1697
19. Song Y., Wang J., Li Y., Du Y., Arteel G.E., Saari J.T., Kang Y.J., and Cai L. Cardiac metallothionein synthesis in streptozotocin-induced diabetic mice, and its protection against diabetes-induced cardiac injury. Am. J. Pathol. 167 (2005) 17-26
20. Mocchegiani E., Giacconi R., Cipriano C., Muzzioli M., Gasparini N., Moresi R., Stecconi R., Suzuki H., Cavalieri E., and Mariani E. MtmRNA gene expression, via IL-6 and glucocorticoids, as potential genetic marker of immunosenescence: lessons from very old mice and humans. Exp. Gerontol. 37 (2002) 349-357
21. Giacconi R., Muti E., Malavolta M., Cipriano C., Costarelli L., Bernardini G., Gasparini N., Mariani E., Saba V., Boccoli G., and Mocchegiani E. The +838 C/G MT2A polymorphism, metals, and the inflammatory/immune response in carotid artery stenosis in elderly people. Mol. Med. 13 (2007) 388-395
22. Singh U., and Jialal I. Oxidative stress and atherosclerosis. Pathophysiology 13 (2006) 129-142
23. Moreno P.R., and Fuster V. New aspects in the pathogenesis of diabetic atherothrombosis. J. Am. Coll. Cardiol. 44 (2004) 2293-2300
24. Giacconi R., Cipriano C., Muti E., Costarelli L., Maurizio C., Saba V., Gasparini N., Malavolta M., and Mocchegiani E. Novel -209A/G MT2A polymorphism in old patients with type 2 diabetes and atherosclerosis: relationship with inflammation (IL-6) and zinc. Biogerontology 6 (2005) 407-413
25. Cipriano C., Malavolta M., Costarelli L., Giacconi R., Muti E., Gasparini N., Cardelli M., Monti D., Mariani E., and Mocchegiani E. Polymorphisms in MT1a gene coding region are associated with longevity in Italian Central female population. Biogerontology 7 (2006) 357-365
26. American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diab. Care. 27 (2004) S5-S10
27. European Society of Hypertension-European Society of Cardiology Guidelines Committee. 2003 European Society of Hypertension-European Society of Cardiology guidelines for the management of arterial hypertension. J. Hypertens. 21 (2003) 1011-1053
28. Ligthart G.J., Corberand J.X., Fournier C., Galanaud P., Hijmans W., Kennes B., Hermelink M.H.K., and Steinmann G.G. Admission criteria for immunogerontological studies in man: the SENIEUR protocol. Mech. Ageing Dev. 28 (1984) 47-55
29. Malavolta M., Costarelli L., Giacconi R., Muti E., Bernardini G., Tesei S., Cipriano C., and Mocchegiani E. Single and three-color flow cytometry assay for intracellular zinc ion availability in human lymphocytes with Zinpyr-1 and double immunofluorescence: relationship with metallothioneins. Cytometry A 69 (2006) 1043-1053
30. Misra R.R., Hochadel J.F., Smith G.T., Cook J.C., Waalkes M.P., and Wink D.A. Evidence that nitric oxide enhances cadmium toxicity by displacing the metal from metallothionein. Chem. Res. Toxicol. 9 (1996) 326-332
31. Saavedra J.E., Shami P.J., Wang L.Y., Davies K.M., Booth M.N., Citro M.L., and Keefer L.K. Esterase sensitive nitric oxide donors of the diazeniumdiolate family: in vitro antileukemic activity. J. Med. Chem. 43 (2000) 261-269
32. Yurkow E.J., and Makhijani P.R. Flow cytometric determination of metallothionein levels in human peripheral blood lymphocytes: utility in environmental exposure assessment. J. Toxicol. Environ. Health A 54 (1998) 445-457
33. West I.C. Radicals and oxidative stress in diabetes. Diab. Med. 17 (2000) 171-180
34. Deedwania P.C. Mechanisms of endothelial dysfunction in the metabolic syndrome. Curr. Diab. Rep. 3 (2003) 289-292
35. Maret W. Cellular zinc and redox states converge in the metallothionein/thionein pair. J. Nutr. 133 (2003) 1460S-1462S
36. Cousins R.J., Liuzzi J.P., and Lichten L.A. Mammalian zinc transport, trafficking, and signals. J. Biol. Chem. 281 (2006) 24085-24089
37. Jacob C., Maret W., and Vallee BL. Control of zinc transfer between thionein, metallothionein, and zinc proteins. Proc. Natl. Acad. Sci. USA 95 (1998) 3489-3494
38. Simon S.F., and Taylor C.G. Dietary zinc supplementation attenuates hyperglycemia in db/db mice. Exp. Biol. Med. 226 (2001) 43-51
39. Al-Maroof R.A., and Al-Sharbatti S.S. Serum zinc levels in diabetic patients and effect of zinc supplementation on glycemic control of type 2 diabetics. Saudi Med. J. 27 (2006) 344-350
40. Zargar A.H., Bashir M.I., Khan A.R., Masoodi S.R., Laway B.A., Wani A.I., and Dar F.A. Copper, zinc and magnesium levels in fibrocalculous pancreatic diabetes. Exp. Clin. Endocrinol. Diabetes 108 (2000) 397-400
41. Gunduz G., Gunduz F., Yucel I., and Senturk U.K. Levels of zinc and magnesium in senile and diabetic senile cataractous lenses. Biol. Trace Elem. Res. 95 (2003) 107-112
42. Prasad A.S., Fitzgerald J.T., Hess J.W., Kaplan J., Pelen F., and Dardenne M. Zinc deficiency in elderly patients. Nutrition 9 (1993) 218-224
43. Nishikawa T., Kukidome D., Sonoda K., Fujisawa K., Matsuhisa T., Motoshima H., Matsumura T., and Araki E. Impact of mitochondrial ROS production in the pathogenesis of insulin resistance. Diabetes Res. Clin. Pract. 77 (2007) S161-S164
44. Chen M.D., Liou S.J., Lin P.Y., Yang V.C., Alexander P.S., and Lin W.H. Effects of zinc supplementation on the plasma glucose level and insulin activity in genetically obese (ob/ob) mice. Biol. Trace Elem. Res. 61 (1998) 303-311
45. Chausmer A.B. Zinc, insulin and diabetes. J. Am. Coll. Nutr. 17 (1998) 109-115
46. Haase H., and Maret W. Protein tyrosine phosphatases as targets of the combined insulinomimetic effects of zinc and oxidants. Biometals 18 (2005) 333-338
47. Wang J., Song Y., Elsherif L., Song Z., Zhou G., Prabhu S.D., Saari J.T., and Cai L. Cardiac metallothionein induction plays the major role in the prevention of diabetic cardiomyopathy by zinc supplementation. Circulation 113 (2006) 544-554